Heartflow (HTFL) vs ICU Medical (ICUI)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Heartflow (HTFL) has outperformed ICU Medical (ICUI) over the past year, gaining 41.1% versus a gain of 32.1%. Heartflow is the larger company by market cap ($4.29 billion vs $3.90 billion), about 1.1 times the size. ICU Medical converts more of its revenue into profit, with a net margin of 0.0% versus -66.3%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | HTFL | ICUI |
|---|---|---|
| Share price | $49.36 | $156.03 |
| Market cap | $4.29B | $3.90B |
| 1-day change | -2.62% | -2.32% |
| YTD return | +69.33% | +9.36% |
| 1-year return | +41.07% | +32.12% |
| 5-year return | — | -32.41% |
| P/E ratio (TTM) | — | 131.12 |
| Forward P/E | — | 16.18 |
| EPS (TTM) | $-0.24 | $1.19 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $176.03M | $2.23B |
| Revenue growth (YoY) | +39.92% | -6.33% |
| Net income (latest FY) | $-116.79M | $732.00K |
| Gross margin | 76.80% | 36.84% |
| Operating margin | -36.39% | 1.92% |
| Net margin | -66.35% | 0.03% |
| 52-week high | $54.32 | $192.85 |
| 52-week low | $20.13 | $112.50 |
| Distance from 52-week high | -9.13% | -19.09% |
| Analyst consensus | none | buy |
| Avg. price target upside | -6.81% | +23.94% |
| Average volume | 1.79M | 278.57K |
| Shares outstanding | 86.95M | 25.01M |
| Employees | 843 | 13,000 |
| Sector | Healthcare | Health Care |
| Industry | Health Information Services | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- ICU Medical is more profitable, keeping 0.0 cents of every revenue dollar as net income versus -66.3 cents for Heartflow.
- Heartflow grew revenue faster in its latest fiscal year (+39.92% vs -6.33%).
- The two companies sit in different sectors: Heartflow in Healthcare and ICU Medical in Health Care.
About Heartflow
HTFL stock →HeartFlow, Inc., a medical technology company, provides non-invasive solutions for diagnosing and managing coronary artery diseases the United States and worldwide. Its HeartFlow Platform uses AI and computational fluid dynamics to creates a personalized 3D model of a patient's heart from a single coronary computed tomography angiography, a specialized type of scan that provides detailed images of the heart's arteries.
Healthcare · Health Information Services · 843 employees
About ICU Medical
ICUI stock →ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical products used in infusion therapy, vascular access, and vital care applications worldwide. It offers Clave needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoLock closed system transfer devices and ChemoClaveTM for preparation and administration of hazardous drugs; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; ClearGuard, SwabCap, and SwabTip disinfection caps; and vascular access products.
Health Care · Medical/Dental Instruments · 13,000 employees
HTFL vs ICUI FAQ
Which is bigger, Heartflow or ICU Medical?
Heartflow (HTFL) is larger, with a market capitalization of $4.29B compared with $3.90B for ICU Medical (ICUI).
Which stock has performed better over the past year, HTFL or ICUI?
HTFL returned +41.07% over the past 12 months, compared with +32.12% for ICUI (price return, excluding dividends). Past performance does not predict future results.
Are Heartflow and ICU Medical in the same industry?
No. Heartflow is in the Healthcare sector, while ICU Medical is in Health Care.